BEE VENOM TREATMENT SPOT

Manufacturer: NATURE REPUBLIC CO., LTD. | Cosmax, Inc
Effective date: 2017-11-20
Label type: HUMAN OTC DRUG LABEL
Version: 3
Source: legacy-cache
Hydrated at: 2026-08-02 01:10:02

Label at a glance#

ProductBEE VENOM TREATMENT SPOT

Active ingredientGLYCERIN

Label structure8 sections

Dosage and administration

Directions 1. Apply an appropriate amount to the problem areas 2. Gently rub to enhance absorption into skin

Label contents#

Full prescribing information#

ACTIVE INGREDIENT

OTC - ACTIVE INGREDIENT SECTION

ACTIVE INGREDIENTS: GLYCERIN (4.05%)

INACTIVE INGREDIENT

INACTIVE INGREDIENT SECTION

INACTIVE INGREDIENTS:

Water, Butylene Glycol, Glycerin, Caprylic/Capric Triglyceride, Simmondsia Chinensis (Jojoba) Seed Oil, 1,2-Hexanediol, Sodium Polyacrylate, Polyglyceryl-3 Methylglucose Distearate, Hydroxyethyl Acrylate/Sodium Acryloyldimethyl Taurate Copolymer, Glyceryl Stearate, Peg-100 Stearate, Phenoxyethanol, Acrylates/C10-30 Alkyl Acrylate Crosspolymer, Arginine, Xylitol, Olea Europaea (Olive) Fruit Oil, Disodium Edta, Beta-Sitosterol, Alcohol Denat., Centella Asiatica Extract, Steareth-4, Cholesterol, Potassium Cetyl Phosphate, Propylene Glycol, Salicylic Acid, Tocopherol, Lavandula Angustifolia (Lavender) Oil, Pinus Sylvestris Leaf Oil, Cananga Odorata Flower Oil, Pollen Extract, Macadamia Ternifolia Seed Oil, Cholesteryl/Behenyl/Octyldodecyl Lauroyl Glutamate, Palmeth-2 Phosphate, Rosmarinus Officinalis (Rosemary) Leaf Oil, Origanum Vulgare Leaf Extract, Salix Alba (Willow) Bark Extract, Chamaecyparis Obtusa Leaf Extract, Pelargonium Graveolens Flower Oil, Melaleuca Alternifolia (Tea Tree) Leaf Oil, Camellia Japonica Flower Extract, Portulaca Oleracea Extract, Scutellaria Baicalensis Root Extract, Lactobacillus/Soybean Ferment Extract, Cinnamomum Cassia Bark Extract, Water, Terminalia Chebula Fruit Extract, Caesalpinia Sappan Bark Extract, Magnolia Obovata Bark Extract, Alcohol, Bee Venom, Lecithin

PURPOSE

OTC - PURPOSE SECTION

PURPOSE: Skin Protectant

WARNINGS

WARNINGS SECTION

WARNINGS:

For external use only. Avoid contact with eyes. Discontinue use if signs of irritation or rashes appear. Replace the cap after use. Keep out of reach of children.

KEEP OUT OF REACH OF CHILDREN

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

KEEP OUT OF REACH OF CHILDREN

INDICATIONS & USAGE

INDICATIONS & USAGE SECTION

Indications & Usage:

Concentrated spot care ointment for acne.

Directions

DOSAGE & ADMINISTRATION SECTION

Directions

1. Apply an appropriate amount to the problem areas 2. Gently rub to enhance absorption into skin

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Image of carton

Product Linked Resources#

Resource, Code type, Value table
Resource	Code type	Value	Equivalent identifiers	Source image
Barcode	EAN-13	8806173425914	GTIN-13: 8806173425914 EAN-13: 8806173425914 GTIN storage (14 digits): 08806173425914	spot carton.jpg

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	SPL version
GLYCERIN	ACTIVE INGREDIENT	PDC6A3C0OX	1
GLYCERIN	ACTIVE MOIETY	PDC6A3C0OX	1
BUTYLENE GLYCOL	INACTIVE INGREDIENT	3XUS85K0RA	1
WATER	INACTIVE INGREDIENT	059QF0KO0R	1

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 4 matching rows.

BEE VENOM TREATMENT SPOT
GLYCERIN
WATER
BUTYLENE GLYCOL

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
51346-365	51346-365-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 3 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
GLYCERIN	PDC6A3C0OX	ACTIB
WATER	059QF0KO0R	IACT
BUTYLENE GLYCOL	3XUS85K0RA	IACT

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 1 · 2 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredient	IID ingredient	UNII	Dosage form / route	Potency	Maximum daily exposure	Match
BUTYLENE GLYCOL	BUTYLENE GLYCOL	3XUS85K0RA	SYSTEM / TRANSDERMAL	8.12 mg		Exact identifier — unii candidate 2 equally ranked IID candidates
BUTYLENE GLYCOL	BUTYLENE GLYCOL	3XUS85K0RA	SYSTEM / TOPICAL		1400 mg	Exact identifier — unii candidate 2 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
62772968-278d-4955-9182-3d372cbb5df7			55e07fbf-7dec-452d-a3aa-765e53575c86	2017-11-20	Warnings	Exact identifier spl id: 62772968-278d-4955-9182-3d372cbb5df7 spl set id: 55e07fbf-7dec-452d-a3aa-765e53575c86

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.